Table 1.
Characteristics of the EVIDENT II population included in this analysis.
| Variables | Total n = 1243 |
Men n = 504 |
Women n = 739 |
|---|---|---|---|
| MetS prevalence (%) 1 | 611 (49.2) | 262 (52.0) | 349 (47.2) |
| Age (years) | 55.94 ± 13.69 | 56.48 ± 13.65 | 54.11 ± 13.65 |
| Waist circumference (cm) | 93.40 ± 12.60 | 98.68 ± 11.22 | 89.82 ± 12.24 |
| SBP (mmHg) | 125.06 ± 16.94 | 129.70 ± 14.83 | 122.31 ± 17.78 |
| DBP (mmHg) | 77.43 ± 10.43 | 79.04 ± 10.45 | 75.65 ± 11.03 |
| MAP (mmHg) | 51.43 ± 13.97 | 55.80 ± 13.33 | 48.46 ± 13.63 |
| HbA1c (%) (n = 1231) |
5.65 ± 0.75 | 5.73 ± 0.80 | 5.60 ± 0.71 |
| FPG (mg/dL) | 93.81 ± 23.10 | 97.32 ± 25.81 | 91.44 ± 20.76 |
| Fasting insulin (µIU/mL) (n = 1153) |
8.09 ± 6.09 | 8.39 ± 6.16 | 7.91 ± 6.03 |
| HOMA-IR (n = 1150) |
1.93 ± 1.70 | 2.07 ± 1.76 | 1.84 ± 1.66 |
| cHDL (mg/dL) | 58.83 ± 15.58 | 51.94 ± 12.47 | 63.51 ± 15.74 |
| Tryglicerides (mg/dL) | 123.54 ± 118.47 | 143.36 ± 143.36 | 110.08 ± 95.89 |
| PWv (m/s) (n = 243) |
7.65 ± 2.01 | 8.24 ± 2.29 | 7.23 ± 1.68 |
| IMT (mm) (n =247) |
0.68 ± 0.11 | 0.71 ± 1.20 | 0.66 ± 0.09 |
| ACR (mg/g) (n = 1041) |
10.99 ± 36.43 | 10.44 ± 28.96 | 11.38 ± 40.85 |
Values are presented in mean ± SD and number (%). 1 Following International Diabetes Federation (IDF) criteria. MetS: metabolic syndrome; SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; HbA1c: glycated hemoglobin A1c; FPG: fasting plasma glucose; HOMA-IR: homeostasis assessment model for insulin resistance; cHDL: high density lipoprotein cholesterol; PWv: pulse wave velocity; IMT: intima media thickness; ACR: albumin-to-creatinine ratio.